TD
Translational Development Acquisition Corp.
TDACW · NASDAQ
$1.40 -6.67% (-$0.10)
1M -24.32%
Market Cap $36.9M
P/E Ratio 6.67x
Div. Yield -
ROE 3.28%
Analýza
AI report o byznysu, financích, ocenění, sentimentu, zprávách a rizicích - napsaný během několika minut.
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/E 6.67x
P/B 0.25x
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
36 /100
Average ROE 3.28%
Asset turnover 0.00x
ROA 3.52%
Debt
0 /100
High Current ratio 0.06x
Debt/Equity N/A
Debt/Assets N/A
Stability
0 /100
Unstable Beta 2.11x
Rev. volatility N/A
Profitable years N/A
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na TDACW
Online
Sector
Financial Services
Industry
Shell Companies
CEO
Michael Hoffman
Employees
2
Headquarters
New York City